LEM Surgical wins new FDA clearance for humanoid surgical robot

LEM Surgical announced today that the FDA granted a new 510(k) clearance for its Dynamis robotic surgical system.

Bern, Switzerland-based LEM Surgical said the milestone introduces further capabilities to its surgical humanoid architecture for the global orthopedic and spine surgery market. It adds individual vertebra tracking using miniature bone‑mounted markers, robotic bi-manual stabilization workflow option, and the introduction of cervical indications.

LEM Surgical designed Dynamis as an integrated, navigation-based robotic platform. The system’s unique upper torso humanoid configuration consolidates into a single compact cart that fits partially beneath the surgical table. It also supports a range of third-party surgical instruments and implants. This optimizes hospital workflow efficiency and  reduces facility adoption friction.

Sign up for Blog Updates